Clinical trial
Safety Study of hMaxi-K Gene Transfer to Treat Overactive Bladder and Detrusor…
NCT00495053 · Urovant Sciences GmbH, Industry · Terminated
Key facts
| NCT number | NCT00495053 |
|---|---|
| Title | Safety Study of hMaxi-K Gene Transfer to Treat Overactive Bladder and Detrusor Overactivity |
| Official title | A Phase 1 Multicenter Study Evaluating the Safety and Potential Activity Of Three Escalating Doses of hMaxi-K Gene Transfer In Female Participants With Overactive Bladder Syndrome and Detrusor Overactivity: Double Blind, Imbalanced Placebo Controlled Design Within 3 Sequential Active Treatment… |
| Lead sponsor | Urovant Sciences GmbH, Industry |
| Collaborators | Ion Channel Innovations Industry |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Overactive Bladder |
| Intervention type | Drug, Other |
| Interventions | hMaxi-K, Placebo |
| Enrollment | 21 |
| Start date | Apr 1, 2007 |
| Primary completion | Jul 1, 2008 |
| Completion | Nov 1, 2009 |
| First posted | Jul 2, 2007 |
| Last update posted | Jun 28, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: